BioNTech

EMA official suggests ditching AstraZeneca jab

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published on June 13.

Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for the over 60s.

New 964,080-dose Pfizer vaccine batch expected in Romania

A new batch of the Pfizer BioNTech COVID-19 vaccine consisting of 964,080 doses is being brought to Romania today, according to the National COVID-19 Vaccination Coordination Committee (CNCAV). The vaccines will be delivered by air and will reach the airports of Otopeni, Cluj-Napoca and Timisoara. Shipment to storage centres is provided by the manufacturing company, including by land.

Covax raises $2.4 bln to help combat jabs shortfall

The Covax vaccine programme secured another $2.4 billion from donors on June 2, but underlined it was still struggling to get enough doses to help poorer countries fight the COVID-19 pandemic.

The scheme is trying to get enough vaccines for 30 percent of the population in 92 of the poorest participating territories - 20 percent in India - with donors covering the cost.

Turkey to receive more batches of Pfizer jab

Turkey will receive 12 million doses of a COVID-19 vaccine developed by Pfizer/BioNTech by the end of next week, the country's health minister has said.

Fahrettin Koca said he spoke with Uğur Şahin, the co-founder of CEO of Germany-based BioNTech, earlier this week and that Şahin confirmed that they obtained export permission for 12 million doses of the injection.

Over 29 million doses of jab administered

The total number of COVID-19 vaccines administered in Turkey has exceeded 29 million doses.

The country rolled out its inoculation program in mid-January, starting with health care workers and the elderly.

Since then, it has been gradually expanding the scope of the inoculation drive to cover more age groups and people at risk.

Pages